A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine ...
The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...
NCI Researcher Presents Research on the Role of White Blood Cells in Bone Metastatic Prostate Cancer
The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune system can contribute to bone metastatic prostate cancer as part of their ...
Morning Overview on MSN
A year of added prostate-cancer therapy cut the odds the disease spreads, a major trial found
Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Winthrop-University Hospital's Clinical Trials Center in Mineola is seeking volunteers with polymyalgia rheumatica (PMR) to participate in a clinical research study of a medication currently used to ...
Orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results